TruAlt Bioenergy Limited (NSE:TRUALT)
India · Delayed Price · Currency is INR 341.25
-5.45 (-1.57%)
At close: Nov 12, 2026
TruAlt Bioenergy Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 27,467 | 17,275 | 19,077 | 12,234 | 7,624 | - | |
Revenue Growth | 57.78% | -9.45% | 55.94% | 60.47% | 45.11% | - |
Cost of Revenue | 18,162 | 11,200 | 12,760 | 8,080 | 5,031 | - |
Gross Profit | 9,306 | 6,075 | 6,317 | 4,154 | 2,593 | - |
Selling, General & Admin | 511.43 | 488.74 | 417.82 | 247.07 | 119.49 | - |
Other Operating Expenses | 3,924 | 2,685 | 2,803 | 2,024 | 1,423 | 0.12 |
Operating Expenses | 5,374 | 4,036 | 3,890 | 2,840 | 1,750 | 0.12 |
Operating Income | 3,932 | 2,038 | 2,427 | 1,314 | 842.96 | -0.12 |
Interest Expense | -1,664 | -1,562 | -1,406 | -1,362 | -345.69 | - |
Interest & Investment Income | 788.26 | 788.26 | 592.07 | 502.67 | - | - |
Currency Exchange Gain (Loss) | -0.27 | -0.27 | -0.27 | 0.77 | - | - |
Other Non Operating Income (Expenses) | -65.19 | 38.46 | -22.74 | -6.3 | -7.41 | - |
EBT Excluding Unusual Items | 2,991 | 1,303 | 1,590 | 448.73 | 489.85 | -0.12 |
Gain (Loss) on Sale of Investments | -2.96 | -2.96 | 4.26 | 0.01 | - | - |
Pretax Income | 2,988 | 1,300 | 1,594 | 448.74 | 489.85 | -0.12 |
Income Tax Expense | 745.15 | 330.85 | 128.04 | 130.66 | 135.25 | - |
Net Income | 2,219 | 968.7 | 1,466 | 318.08 | 354.6 | -0.12 |
Preferred Dividends & Other Adjustments | - | - | 5.14 | 58.65 | 29.33 | - |
Net Income to Common | 2,219 | 968.7 | 1,461 | 259.43 | 325.27 | -0.12 |
Net Income Growth | 44.93% | -33.71% | 463.25% | -20.24% | - | - |
Shares Outstanding (Basic) | 86 | 78 | 70 | 61 | 46 | 0 |
Shares Outstanding (Diluted) | 86 | 78 | 70 | 61 | 46 | 0 |
Shares Change | 22.80% | 12.11% | 14.23% | 33.28% | 75023.49% | - |
EPS (Basic) | 25.87 | 12.39 | 20.94 | 4.25 | 7.10 | -2.03 |
EPS (Diluted) | 25.79 | 12.30 | 20.94 | 4.25 | 7.10 | -2.03 |
EPS Growth | 17.69% | -41.26% | 392.98% | -40.16% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -7,916 | -8,063 | 824.31 | -3,213 | -420.48 | -0 |
Free Cash Flow Per Share | -92.28 | -103.09 | 11.81 | -52.61 | -9.18 | -0.00 |
Gross Margin | 33.88% | 35.16% | 33.11% | 33.95% | 34.01% | - |
Operating Margin | 14.32% | 11.80% | 12.72% | 10.74% | 11.06% | - |
Profit Margin | 8.08% | 5.61% | 7.66% | 2.12% | 4.27% | - |
Free Cash Flow Margin | -28.82% | -46.67% | 4.32% | -26.27% | -5.51% | - |
EBITDA | 4,855 | 2,886 | 3,084 | 1,883 | 1,050 | 64.57 |
EBITDA Margin | 17.68% | 16.71% | 16.16% | 15.39% | 13.78% | - |
D&A For EBITDA | 923.14 | 847.42 | 656.87 | 569.17 | 207.52 | 64.69 |
EBIT | 3,932 | 2,038 | 2,427 | 1,314 | 842.96 | -0.12 |
EBIT Margin | 14.32% | 11.80% | 12.72% | 10.74% | 11.06% | - |
Effective Tax Rate | 24.93% | 25.46% | 8.03% | 29.12% | 27.61% | - |
Revenue as Reported | 28,229 | 18,140 | 19,685 | 12,802 | 7,624 | - |
Advertising Expenses | - | 10.57 | 13.7 | 2.31 | 33.55 | - |